Zhen Su

Zhen Su

Company: Marengo Therapeutics Inc.

Job title: Chief Executive Officer & Director

Seminars:

Industry Leaders’ Fireside Chat: What’s Next for T-Cell Receptor Therapies? 8:30 am

Appreciating the wealth of TCR therapy advances and exploring the data to secure clinical validation Examining the range of TCR modalities and their respective targeting benefits Discussing the advances in allogeneic TCR approaches to determine the future directions for TCR therapiesRead more

day: Conference Day One

Panel: Comparing the Characteristics of TCR-T Cell Therapies & TCR Bispecifics (& More!) to Reaffirm their Unique Benefits 2:00 pm

Comparing relative affinities, potencies and safety considerations of T-cell therapies and bispecifics Assessing indications and patients where each TCR modality could be best suited to treat What other modalities can TCR therapies venture into in the future?Read more

day: Conference Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.